Current Report · Items 3.01, 8.01 · 8-K
DIH Holding US, Inc.
DHAIOTCEQUITYCurrent
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Other Events
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 5, 2025, DIH Holding US, Inc. (the “Company”) received a determination letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to deny the Company’s request to continue its listing on Nasdaq.…
Filed Nov 6, 2025Accepted Nov 6, 2025, 1:03 AM ESTCIK 1883788Accession 0001493152-25-020954
Company context
DIH stands for the vision to “Deliver Inspiration & Health” to improve the daily lives of millions of people with disabilities and functional impairments through providing devices and solutions enabling intensive rehabilitation. DIH is a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Built through the mergers of global-leading niche technology providers, DIH is a transformative rehabilitation solutions provider and consolidator of a largely fragmented and manual-labor-driven industry.
Current securities
Historical securities (4)
Disclosure sections
Items 3.01, 8.01Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 3.01Item 3.01 - Notice of Delisting
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On
November 5, 2025, DIH Holding US, Inc. (the “Company”) received a determination
letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has
determined to deny the Company’s request to continue its listing on Nasdaq. Accordingly, the Company’s shares will be delisted
from Nasdaq and trading in the Company’s securities will be suspended at the open of trading on November 7, 2025.
As
previously disclosed, the Listing Qualifications Staff (“Staff”) of Nasdaq notified
the Company that it was not in compliance with Listing Rules 5250(c)(1), 5450(a)(1), 5450(b)(2&3), and 5450(b)(2)(A). A hearing before
the Panel on these matters was held on October 16, 2025.
The
Company has 15 days after the date of the Panel’s decision to request that the Nasdaq Listing and Hearing Review Council (the “Council”)
review the decision, or the Council may, on its own motion, determine to review the Panel’s decision within 45 calendar days after
issuance of the written decision. The Company does not intend to request a review of the decision.
As
a result of the suspension in trading and delisting, there may be a very limited market in which the Company’s shares
are traded. The Company intends to have its securities quoted in the Over-the-Counter market under
the same symbols although the Company’s
stockholders may find it difficult to sell their shares of the Company and the trading price of the Company’s securities, if any,
may be adversely affected.
Item 8.01Item 8.01 - Other Events
Item
8.01 Other Events
As
previously disclosed in its public filings, the Company and its auditors believe there is substantial doubt about its ability to continue
as a going concern. As a result of the Nasdaq delisting described in Item 3.02 hereto, the Company has concluded that sources of additional
capital it needs to fund its day to day operations will be unavailable. As such, the Company has determined to suspend its operations
while it evaluates all strategic alternatives.